… fatty acids in the form of docosahexaenoic acid (DHA, 22:6n-3) plus eicosapentaenoic acid
(… The beneficial effects on cardiovascular disease and related mortality including various risk …

… The effects of eicosapentaenoic acid (EPA) 600 and 1800 mg/day and docosahexaenoic
acid (DHA) 600 mg/day versus olive oil placebo on cardiovascular disease (CVD) risk factors …

… Our understanding of the cardiovascular disease (CVD) benefits of α-linolenic acid (ALA, 18:…
research on eicosapentaenoic acid (EPA, 20:5n–3) and docosahexaenoic acid (DHA, 22:6n…

… acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-… of both recurrence of coronary
heart disease (CHD) events or … been shown to reduce cardiovascular disease (CVD) risk. …

… of eicosapentaenoic acid (EPA) and docosahexaenoic acid (… studies of cardiovascular
disease prevention with n-3 FAs. … fish and fish oils provides cardiovascular disease protection. In …

Full article: Omega-3 polyunsaturated fatty acids focusing on eicosapentaenoic acid and
docosahexaenoic acid in the prevention of cardiovascular diseases: a review of the state-of-the-…

… acid (EPA) and docosahexaenoic acid (DHA) supplements on risk factors associated with
cardiovascular disease. … containing EPA and DHA on risk factors for cardiovascular disease. …

… docosahexaenoic acid (DHA), protect against cardiovascular diseases, and EPA/arachidonic
acid … in serum are potential risk markers for coronary artery disease (CAD). The purpose of …

… ‐3 polyunsaturated fatty acids (n‐3 LC‐PUFAs) ecosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA) has been shown to reduce the risk of cardiovascular disease (CVD) in …

… to reduce cardiovascular events should be identified1). Vascular endothelial dysfunction is
recognized to be a critical factor in the development of coronary artery disease (CAD)2), and …